small win: dual agonist stopped being a problem at week 50
small win: dual agonist stopped being a problem at week 50, and the part I actually want to talk about is at the bottom. Week 7 was the first time the scale moved after a five-week stall. I changed nothing in that window. On comparing yourself with the trial number. SURMOUNT-1 reported roughly 21% mean body weight…
Are you comparing yourself with the trial mean or with the people who post the most?
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
Not sure that follows. You went up a step and changed your training in the same fortnight.
dual agonist, so the GIP arm is doing something the sema threads will not tell you about
dual agonist, so the GIP arm is doing something the sema threads will not tell you about
Not sure about this bit. The GIP arm being real does not tell you that it is what caused your particular week.
Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.
week 2 is early to draw any conclusion at all
Agree. The GIP component is the interesting half and it barely gets discussed outside c/glp1science.
SURMOUNT-1 landed around 21% at 72 weeks on the top arm